August 01, 2013 – New Orleans CityBusiness
Drug development is a very long and complex process, and it presents some unique obstacles to emerging startups. In this article, MiniVax and LaCell discuss some of the complexities of pharmaceutical research, product development, and fundraising.
New Orleans BioInnovation Center granted funds to pilot diversity program in Life-Sciences Entrepreneurship Investment from JPMorgan Chase will help launch program in partnership with Xavier University of Louisiana NEW ORLEANS…
New technology revolutionizes DNA testing of sexual assault samples InnoGenomics SpermX™ delivers reliable results to solve sexual assault crimes NEW ORLEANS (March 28, 2023) – Addressing a long-term shortcoming in…
Local Biotech Company is Improving Clinical Care for Animals PetVet Dx celebrated recent expansion and future plans at a community event Friday NEW ORLEANS (March 31, 2023) Local biotech company…